Early detection of immune checkpoint inhibitor-related subclinical cardiotoxicity: A pilot study by using speckle tracking imaging and three-dimensional echocardiography

BackgroundEarly detection of subclinical cardiotoxicity of immune checkpoint inhibitor (ICI) therapy can be challenging.ObjectiveTo evaluate subclinical cardiac dysfunction using two-dimensional speckle tracking imaging (2D-STI) and three-dimensional echocardiography in Chinese patients.MethodsFifty...

Full description

Bibliographic Details
Main Authors: Aiqing Xu, Ming Yuan, Xiaoping Zhan, Gangjian Zhao, Guanyu Mu, Tingting Wang, Hailong Hu, Huaying Fu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-12-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2022.1087287/full
_version_ 1811289868858294272
author Aiqing Xu
Aiqing Xu
Ming Yuan
Xiaoping Zhan
Gangjian Zhao
Guanyu Mu
Tingting Wang
Hailong Hu
Huaying Fu
author_facet Aiqing Xu
Aiqing Xu
Ming Yuan
Xiaoping Zhan
Gangjian Zhao
Guanyu Mu
Tingting Wang
Hailong Hu
Huaying Fu
author_sort Aiqing Xu
collection DOAJ
description BackgroundEarly detection of subclinical cardiotoxicity of immune checkpoint inhibitor (ICI) therapy can be challenging.ObjectiveTo evaluate subclinical cardiac dysfunction using two-dimensional speckle tracking imaging (2D-STI) and three-dimensional echocardiography in Chinese patients.MethodsFifty-five consecutive patients with malignant tumors treated by immunotherapy were included. They were examined by echocardiography before immunotherapy and after immunotherapy. Left ventricular ejection fraction (LVEF) was calculated in three-dimensional imaging. Moreover, left ventricular global longitudinal peak systolic strain (LVGLS), left ventricular global circumferential peak systolic strain (LVGCS), right ventricular global longitudinal systolic strain (RVGLS), right ventricular free wall longitudinal peak systolic strain (RVFWLS), and tricuspid annular plane systolic excursion (TAPSE) were evaluated. Clinical and laboratory parameters were recorded. Cardiac toxicity events were defined as the presence of heart failure symptoms, LVEF reduction, and increase in troponin. Subclinical cardiac toxicity was defined as cardiac dysfunction associated with ICI treatment, with absent or delayed ICI-associated cardiotoxicity clinical symptoms.ResultsCompared with baseline, the LVGLS, TAPSE, and RVGLS significantly deteriorated after ICI treatment [(–18.63 ± 2.53)% vs. (–17.35 ± 2.58)%, P = 0.000; 18.29 ± 6.23 vs. 14.57 ± 3.81, P = 0.0001; and (–18.45 ± 4.65)% vs. (–14.98 ± 3.85)%, P = 0.0001, respectively]. LVGLS (–17.35 ± 2.58, P = 0.000), TAPSE (14.57 ± 3.81, P = 0.0001), and RVGLS [(–14.98 ± 3.85)%, P = 0.0001] were decreased after ICI immunotherapy. Kaplan-Meier curve analysis showed that LVGLS was more sensitive than the cardiac toxicity events to assess ICI-related subclinical cardiac dysfunction (log-rank P = 0.205). The ROC curve showed that the cutoff value of ΔLVGLS was -13%.ConclusionSubclinical cardiac dysfunction can be detected using two-dimensional speckle-tracking imaging. LVGLS, RVGLS, and TAPSE are more sensitive indices for detection.Clinical trial registration[https://www.chictr.org.cn/showprojen.aspx?proj=27498], identifier [ChiCTR1800016216].
first_indexed 2024-04-13T04:01:40Z
format Article
id doaj.art-fa50571ed48f4084a2f9e817d44bf386
institution Directory Open Access Journal
issn 2297-055X
language English
last_indexed 2024-04-13T04:01:40Z
publishDate 2022-12-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cardiovascular Medicine
spelling doaj.art-fa50571ed48f4084a2f9e817d44bf3862022-12-22T03:03:28ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2022-12-01910.3389/fcvm.2022.10872871087287Early detection of immune checkpoint inhibitor-related subclinical cardiotoxicity: A pilot study by using speckle tracking imaging and three-dimensional echocardiographyAiqing Xu0Aiqing Xu1Ming Yuan2Xiaoping Zhan3Gangjian Zhao4Guanyu Mu5Tingting Wang6Hailong Hu7Huaying Fu8Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, ChinaDepartment of Cardiology, Tianjin Medical University General Hospital, Tianjin, ChinaTianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, ChinaTianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, ChinaDepartment of Urology, Second Hospital of Tianjin Medical University, Tianjin, ChinaTianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, ChinaTianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, ChinaDepartment of Urology, Second Hospital of Tianjin Medical University, Tianjin, ChinaTianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, ChinaBackgroundEarly detection of subclinical cardiotoxicity of immune checkpoint inhibitor (ICI) therapy can be challenging.ObjectiveTo evaluate subclinical cardiac dysfunction using two-dimensional speckle tracking imaging (2D-STI) and three-dimensional echocardiography in Chinese patients.MethodsFifty-five consecutive patients with malignant tumors treated by immunotherapy were included. They were examined by echocardiography before immunotherapy and after immunotherapy. Left ventricular ejection fraction (LVEF) was calculated in three-dimensional imaging. Moreover, left ventricular global longitudinal peak systolic strain (LVGLS), left ventricular global circumferential peak systolic strain (LVGCS), right ventricular global longitudinal systolic strain (RVGLS), right ventricular free wall longitudinal peak systolic strain (RVFWLS), and tricuspid annular plane systolic excursion (TAPSE) were evaluated. Clinical and laboratory parameters were recorded. Cardiac toxicity events were defined as the presence of heart failure symptoms, LVEF reduction, and increase in troponin. Subclinical cardiac toxicity was defined as cardiac dysfunction associated with ICI treatment, with absent or delayed ICI-associated cardiotoxicity clinical symptoms.ResultsCompared with baseline, the LVGLS, TAPSE, and RVGLS significantly deteriorated after ICI treatment [(–18.63 ± 2.53)% vs. (–17.35 ± 2.58)%, P = 0.000; 18.29 ± 6.23 vs. 14.57 ± 3.81, P = 0.0001; and (–18.45 ± 4.65)% vs. (–14.98 ± 3.85)%, P = 0.0001, respectively]. LVGLS (–17.35 ± 2.58, P = 0.000), TAPSE (14.57 ± 3.81, P = 0.0001), and RVGLS [(–14.98 ± 3.85)%, P = 0.0001] were decreased after ICI immunotherapy. Kaplan-Meier curve analysis showed that LVGLS was more sensitive than the cardiac toxicity events to assess ICI-related subclinical cardiac dysfunction (log-rank P = 0.205). The ROC curve showed that the cutoff value of ΔLVGLS was -13%.ConclusionSubclinical cardiac dysfunction can be detected using two-dimensional speckle-tracking imaging. LVGLS, RVGLS, and TAPSE are more sensitive indices for detection.Clinical trial registration[https://www.chictr.org.cn/showprojen.aspx?proj=27498], identifier [ChiCTR1800016216].https://www.frontiersin.org/articles/10.3389/fcvm.2022.1087287/fullsubclinical cardiotoxicityechocardiographystrainTAPSEICIs
spellingShingle Aiqing Xu
Aiqing Xu
Ming Yuan
Xiaoping Zhan
Gangjian Zhao
Guanyu Mu
Tingting Wang
Hailong Hu
Huaying Fu
Early detection of immune checkpoint inhibitor-related subclinical cardiotoxicity: A pilot study by using speckle tracking imaging and three-dimensional echocardiography
Frontiers in Cardiovascular Medicine
subclinical cardiotoxicity
echocardiography
strain
TAPSE
ICIs
title Early detection of immune checkpoint inhibitor-related subclinical cardiotoxicity: A pilot study by using speckle tracking imaging and three-dimensional echocardiography
title_full Early detection of immune checkpoint inhibitor-related subclinical cardiotoxicity: A pilot study by using speckle tracking imaging and three-dimensional echocardiography
title_fullStr Early detection of immune checkpoint inhibitor-related subclinical cardiotoxicity: A pilot study by using speckle tracking imaging and three-dimensional echocardiography
title_full_unstemmed Early detection of immune checkpoint inhibitor-related subclinical cardiotoxicity: A pilot study by using speckle tracking imaging and three-dimensional echocardiography
title_short Early detection of immune checkpoint inhibitor-related subclinical cardiotoxicity: A pilot study by using speckle tracking imaging and three-dimensional echocardiography
title_sort early detection of immune checkpoint inhibitor related subclinical cardiotoxicity a pilot study by using speckle tracking imaging and three dimensional echocardiography
topic subclinical cardiotoxicity
echocardiography
strain
TAPSE
ICIs
url https://www.frontiersin.org/articles/10.3389/fcvm.2022.1087287/full
work_keys_str_mv AT aiqingxu earlydetectionofimmunecheckpointinhibitorrelatedsubclinicalcardiotoxicityapilotstudybyusingspeckletrackingimagingandthreedimensionalechocardiography
AT aiqingxu earlydetectionofimmunecheckpointinhibitorrelatedsubclinicalcardiotoxicityapilotstudybyusingspeckletrackingimagingandthreedimensionalechocardiography
AT mingyuan earlydetectionofimmunecheckpointinhibitorrelatedsubclinicalcardiotoxicityapilotstudybyusingspeckletrackingimagingandthreedimensionalechocardiography
AT xiaopingzhan earlydetectionofimmunecheckpointinhibitorrelatedsubclinicalcardiotoxicityapilotstudybyusingspeckletrackingimagingandthreedimensionalechocardiography
AT gangjianzhao earlydetectionofimmunecheckpointinhibitorrelatedsubclinicalcardiotoxicityapilotstudybyusingspeckletrackingimagingandthreedimensionalechocardiography
AT guanyumu earlydetectionofimmunecheckpointinhibitorrelatedsubclinicalcardiotoxicityapilotstudybyusingspeckletrackingimagingandthreedimensionalechocardiography
AT tingtingwang earlydetectionofimmunecheckpointinhibitorrelatedsubclinicalcardiotoxicityapilotstudybyusingspeckletrackingimagingandthreedimensionalechocardiography
AT hailonghu earlydetectionofimmunecheckpointinhibitorrelatedsubclinicalcardiotoxicityapilotstudybyusingspeckletrackingimagingandthreedimensionalechocardiography
AT huayingfu earlydetectionofimmunecheckpointinhibitorrelatedsubclinicalcardiotoxicityapilotstudybyusingspeckletrackingimagingandthreedimensionalechocardiography